Accordingly, we used mRNA expression of the pan T-cell marker CD3E as a metric for T-cell abundance within a tumor [12], and examined correlations between expression of CD3E and putative targets across 9,601 human tumors spanning 31 cancer types. The gene discussed is CD3E; the disease is cancer.